FDA Clears Hypertension Drug for Youngsters

February 12, 2010 |

1 min read

MedPage Today -- The FDA has approved the antihypertensive olmesartan (Benicar) for patients ages 6 to 16, manufacturer Daiichi Sankyo announced.